Atom Investors LP Intercept Pharmaceuticals, Inc. Transaction History

Atom Investors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $389,634 - $760,926	-20,157 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $1.03 Million - $1.78 Million	-41,896 Reduced 67.52%	20,157 $498,000
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $891,955 - $1.22 Million	22,818 Added 58.16%	62,053 $2.57 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $470,595 - $927,487	10,077 Added 34.56%	39,235 $1.88 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $2.6 Million - $6.37 Million	-53,704 Reduced 64.81%	29,158 $1.84 Million

Q4 2019 Feb 13, 2020	SELL	$57.36 - $124.1 $1.99 Million - $4.3 Million	-34,681 Reduced 29.5%	82,862 $10.3 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $6.9 Million - $9.46 Million	117,543 New	117,543 $7.8 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.